Sugi Predict

Sugi Predict / Compounds / SCHEMBL774819

SCHEMBL774819

SCHEMBL774819

O=C(O)c1ccc(Cl)c(I)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.65
▸ MAPT P10636 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ TPMT P51580 3/20 0.52
▸ SRD5A2 P31213 2/20 0.52
▸ ALOX15 P16050 1/20 0.48
▸ TP53 P04637 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA6 P23280 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261681 0.91 TSHR (0.55) TSHRMAPTALDH1A1TPMTSRD5A2
SCHEMBL9212477 0.83 TSHR (0.65) TSHRMAPTALDH1A1TPMTSRD5A2
SCHEMBL2964828 0.83 TSHR (0.43) TSHRMAPTALDH1A1TPMTSRD5A2
SCHEMBL5310506 0.82 MEN1 (0.51) TSHRMAPTKDM4EPOLBL3MBTL1
SCHEMBL2954394 0.81 PARP1 (0.49) TSHRMAPTALDH1A1KMT2A
SCHEMBL8352471 0.79 TSHR (1.00) TSHRMAPTALDH1A1SRD5A2ALOX15
SCHEMBL371998 0.79 TSHR (1.00) TSHRMAPTALDH1A1SRD5A2ALOX15
SCHEMBL29353637 0.79 TSHR (1.00) TSHRMAPTALDH1A1SRD5A2ALOX15
SCHEMBL29364242 0.79 TPMT (0.58) TSHRMAPTALDH1A1TPMTSRD5A2
SCHEMBL2723610 0.79 TPMT (0.58) TSHRMAPTALDH1A1TPMTSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400555-A1 Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors INITIAL THERAPEUTICS, INC. (US) 2024-12-05 — — US disclosed
WO-2024226875-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR ATTENUATION OF MAMMALIAN TRANSLATION OF C-MYC OR N-MYC PROTEINS OF THE MYC PROTO-ONCOGENE FAMILY OF BHLH TRANSCRIPTION FACTORS INITIAL THERAPEUTICS, INC. (US) 2024-10-31 — — WO disclosed
EP-3584239-B1 O-AMINOHETEROARYL ALKYNYL-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2024-09-11 — — EP disclosed
US-20240287053-A1 COMPOUND, ENDOTHELIN-A RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION ALCHEMEDICINE, INC. (JP) 2024-08-29 — — US disclosed
EP-4361146-A1 COMPOUND, ENDOTHELIN-A RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION Alchemedicine, Inc. (JP) 2024-05-01 — — EP disclosed
CN-117255791-A Compounds, endothelin A receptor antagonists and pharmaceutical compositions 亚克医药株式会社 2023-12-19 — — CN disclosed
CN-117069650-A Alkynyl compound, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-11-17 — — CN disclosed
WO-2022270487-A1 COMPOUND, ENDOTHELIN-A RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION 株式会社アークメディスン 2022-12-29 — — WO disclosed
EP-3246327-B1 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF SI CHUAN UNIV (CN) 2022-11-23 — — EP disclosed
CN-111662227-B O-aminopyridine alkyne compound and preparation method and application thereof 中国科学院上海药物研究所 2022-07-05 — — CN disclosed
EP-1272468-A1 INDOLIN-2-ONE DERIVATIVES, PREPARATION AND THEIR USE AS OCYTOCIN RECEPTOR LIGANDS Sanofi-Aventis (FR) 2003-01-08 — — EP disclosed
EP-1268423-A1 INDOLE DERIVATIVES AS MCP-1 RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2003-01-02 — — EP disclosed
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 — — US disclosed
WO-2001081316-A2 SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS ABBOTT LABORATORIES (US) 2001-11-01 — — WO disclosed
WO-2001074775-A1 INDOLIN-2-ONE DERIVATIVES, PREPARATION AND THEIR USE AS OCYTOCIN RECEPTOR LIGANDS SANOFI-SYNTHELABO (FR) 2001-10-11 — — WO disclosed
EP-1124821-A1 COMPOUNDS AstraZeneca AB (SE) 2001-08-22 — — EP disclosed
WO-2001051467-A1 INDOLE DERIVATIVES AS MCP-1 RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2001-07-19 — — WO disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 — — EP disclosed
WO-2000027842-A1 COMPOUNDS ASTRAZENECA AB (SE) 2000-05-18 — — WO disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287053-A1 COMPOUND, ENDOTHELIN-A RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION EDNRA, EDNRB, ECE1 TSHR 227/4885MAPT 3017/4885ALDH1A1 3367/4885
US-20240400555-A1 Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors MYCBP, MYC, MYCBP2 TSHR 4270/4885MAPT 2934/4885ALDH1A1 3684/4885
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 TSHR 3465/4885MAPT 1802/4885ALDH1A1 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.